Study of Clinical Manifestations of Visceral Leishmaniasis in Children of Basra Province
Keywords:
Visceral leishmaniasis fever, HSMAbstract
Leishmaniasis in some nations, including Iraq, is considered as a significant public health issue due to its significant influence on morbidity, which places a significant cost on national health. It is more prevalent in the centre, south, and west of the country. The present study describe 85 child patients (46 males and 39 females) with visceral leishmaniasis in Basra province/Southern Iraq 81% less than two years old. The predominant clinical features in these cases were fever and anaemia 100%, hepatosplenomegaly 70.5%, pale 65% and cough 45.8%. weight loss, abdominal distention, diarrhea and sweating were have fewer rates.
Downloads
References
Abbate, J. M., Arfuso, F., Napoli, E., Gaglio,
G., Giannetto, S., Latrofa, M. S.,
Otranto, D., & Brianti, E. (2019).
Leishmania infantum in wild animals in
endemic areas of southern Italy.
Comparative Immunology, Microbiology
and Infectious Diseases, 67, 101374.
Al-Orainey, I.O., Gasim, I.Y.; Singh, L.M.,
Ibrahim, B., Ukabam, S.O, Gonchikar, D. et
al.(1994): Visceral Leishmaniasis in Gizan ,
Saudi Arabia. Ann Saud Med.; 14: 396-398.
Aronson, N., Copeland, N., & Magill, A.
(2020). Leishmania Species: Visceral
(Kala-Azar), Cutaneous, and Mucosal
Leishmaniasis. Mandell, Douglas and
Bennett’s Principles and Practice of
Infectious Diseases, 3321–3340.
Chappuis, F., Sundar, S., Hailu, A., Ghalib,
H., Rijal, S., Peeling, R. W., Alvar, J., &
Boelaert, M. (2007). Visceral
leishmaniasis: what are the needs for
diagnosis, treatment and control? Nature
Reviews Microbiology, 5(11), 873–882.
Dayakar, A., Chandrasekaran, S., Kuchipudi, S.
V, & Kalangi, S. K. (2019). Cytokines: key
determinants of resistance or disease
progression in visceral leishmaniasis:
opportunities for novel diagnostics and
immunotherapy. Frontiers in Immunology,
, 670.
Jervis, S., Chapman, L. A. C., Dwivedi, S.,
Karthick, M., Das, A., Le Rutte, E. A.,
Courtenay, O., Medley, G. F., Banerjee,
I., & Mahapatra, T. (2017). Variations in
visceral leishmaniasis burden, mortality
and the pathway to care within Bihar,
India. Parasites & Vectors, 10(1), 1–17.
Jha, A., & Ramesh, V. (2016). Protozoal
Diseases. Comprehensive Approach to
Infections in Dermatology, 7(9), 395.
Nori L, Al-Jeboori TI; (1979): Kala-azar in
Iraq. An epidemiological and clinical
study. J. Fac. Baghdad, 15: 72-85.
Pearson, R. D., & de Queiroz Sousa, A. (1996).
Clinical spectrum of leishmaniasis. Clinical
Infectious Diseases, 1–11.
Pedrosa, C. M. (2017). Clinical manifestations of
visceral leishmaniasis (American visceral
leishmaniasis). The Epidemiology and
Ecology of Leishmaniasis; Claborn, D., Ed.;
IntechOpen: London, UK, 17–30.
Rageh, H.A.; (1990): Visceral Leishrnaniasis
in the Yemen-a report of 72 cases in Taiz.
Saudi Med J.; 11: 105-107.
Sampaio, M. J. A. de Q., Cavalcanti, N. V.,
Alves, J. G. B., Fernandes Filho, M. J. C.,
& Correia, J. B. (2010). Risk factors for
death in children with visceral
leishmaniasis. PLoS Neglected Tropical
Diseases, 4(11), e877.
Solimando, A. G., Coniglio, G., Desantis, V.,
Lauletta, G., Bavaro, D. F., Diella, L.,
Cirulli, A., Iodice, G., Santoro, P., &
Cicco, S. (2022). A Challenging Case of
Visceral Leishmaniasis. Reports, 5(2), 23.
Tarekegn, B., & Tamene, A. (2021). Clinical and
laboratory profiles of visceral leishmaniasis
among adult patients admitted to Felege
Hiwot Hospital, Bahir Dar, Ethiopia. SAGE
Open Medicine, 9, 20503121211036788.
Zijlstra, E.E., and el-Hassan, A.M. (2001):
Leishmaniasis in Sudan. Visceral
leishmaniasis. Trans. Roy. Soc. Trop.
Med. Hyg., 95(1):27-58.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
